Apollo Hospitals is targeting an addition of over 5,800 beds over the next five years, alongside plans to list its digital and pharmacy businesses separately. The company reported a 34% profit rise in Q1 FY27. Investors are watching how the company manages the initial costs of these new hospitals while proceeding with its corporate restructuring.
Apollo Hospitals Enterprise Limited has announced an aggressive growth strategy, aiming to add more than 5,800 beds to its network over the next five years. This expansion plan follows a strong financial performance in the first quarter of the 2027 fiscal year, where the company reported a 21% year-on-year growth in consolidated revenue and a 34% increase in profit after tax to ₹610.4 crore.
Scaling Up Capacity
The company is focused on scaling its hospital network, with recent milestones including the commissioning of a 180-bed facility in Sarjapur, Bengaluru. The broader expansion pipeline targets key cities such as Delhi, Hyderabad, Ranchi, Indore, and Guwahati. A major component of this strategy is the development of advanced cancer-care centers, including projects in Delhi and Hyderabad that will feature proton therapy. This focus on specialized care is intended to cater to growing demand for complex medical treatments.
Digital Business Restructuring
Alongside its hospital expansion, Apollo is moving forward with the reorganization of its digital health and pharmacy businesses. The plan involves carving out these operations, which include Apollo 24/7 and the pharmacy division, into a new entity. Shareholders and creditors have already approved this composite scheme of arrangement as of June 2026. This restructuring is a significant step toward a potential independent listing of the digital and pharmacy businesses, which could unlock value for shareholders. The company aims to complete this process with an eye toward a potential exchange listing by the fourth quarter of FY27, depending on the necessary regulatory clearances.
Financial Context and Execution Risks
While the company’s operating margins improved to 15.5% in the first quarter of FY27, investors are tracking the financial impact of the new capacity. Like many healthcare providers, opening new hospitals brings initial cost pressures. In the recent quarter, newer units comprising 380 beds reported an EBITDA loss of ₹38 crore. This is a common phase for newly commissioned facilities as they take time to reach full operational capacity and stabilize their patient intake.
Looking ahead, the primary task for the company is to manage the execution of its large-scale bed addition without creating excessive debt pressure. With net debt standing at ₹7,481 million as of June 30, 2026, the company will need to balance the funding requirements for its expansion projects with its operational cash flow. The next important steps for shareholders will be the operational ramp-up of the newly commissioned beds in Sarjapur and the progress of the regulatory approvals for the digital business demerger.